Pixium Vision
A bioelectronics company that developed bionic vision systems for retinal diseases.
ALPIX | PA
Overview
Corporate Details
- ISIN(s):
- FR0011950641 (+1 more)
- LEI:
- 96950046OPLRLKKEOO08
- Country:
- France
- Address:
- 74 RUE DU FBG ST ANTOINE, 75012 PARIS 12
- Website:
- https://www.pixium-vision.com/
- Sector:
- Manufacturing
Description
Pixium Vision was a bioelectronics company that developed bionic vision systems to restore partial sight for patients with retinal diseases. Its core technology, the PRIMA System, is a photovoltaic subretinal implant designed to treat vision loss from advanced atrophic dry age-related macular degeneration (dry AMD). The system uses specialized glasses to project near-infrared light onto the implant, which converts the light into electrical signals to stimulate retinal cells and create a form of prosthetic vision. The company's assets, including the PRIMA technology and its ongoing European pivotal trial (PRIMAvera), were acquired by Science Corporation in late 2023. The trials and device manufacturing are now sponsored by La Science SAS.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-07-13 10:43 |
Pixium Vision annonce une suspension de cours
|
French | 199.9 KB | ||
| 2021-07-01 14:37 |
RAPPORT ANNUEL 2020
|
French | 3.4 MB | ||
| 2021-05-27 18:00 |
Descriptif du programme de rachat d’actions autorisé par l’Assemblée Générale M…
|
French | 195.5 KB | ||
| 2021-05-26 18:00 |
Communiqué sur la composition du bureau de l’Assemblée Générale Mixte du 27 mai…
|
French | 224.5 KB | ||
| 2021-05-12 18:00 |
Pixium Vision annonce le tirage de la dernière tranche de 1,5 M€ de valeur nomi…
|
French | 183.1 KB | ||
| 2021-05-10 18:00 |
General Meeting of 27 May 2021 Procedures for participating
|
English | 200.8 KB | ||
| 2021-05-10 18:00 |
Assemblée Générale du 27 mai 2021 rappel des modalités de participation
|
French | 214.1 KB | ||
| 2021-04-19 20:00 |
Pixium Vision annonce le tirage d’une nouvelle tranche de 1,5 M€ de valeur nomi…
|
French | 228.2 KB | ||
| 2021-04-19 20:00 |
Pixium Vision announces the drawdown of a further tranche, with a nominal value…
|
English | 226.7 KB | ||
| 2021-04-16 18:30 |
Pixium Vision annonce sa position de trésorerie au 31 mars 2021 et fait le poin…
|
French | 255.3 KB | ||
| 2021-04-07 07:00 |
Pixium Vision annonce l’implantation réussie du premier patient de l’étude pivo…
|
French | 211.3 KB | ||
| 2021-04-07 07:00 |
Pixium Vision announces first patient successful implantation in Prima System p…
|
English | 209.8 KB | ||
| 2021-04-03 01:30 |
Termination of the business combination with Second Sight Medical Products, Inc.
|
English | 239.3 KB | ||
| 2021-04-03 01:30 |
Abandon du rapprochement avec Second Sight Medical Products, Inc.
|
French | 245.7 KB | ||
| 2021-03-30 07:00 |
Pixium Vision annonce de nouveaux résultats probants pour son Système Prima, dé…
|
French | 222.7 KB |
Automate Your Workflow. Get a real-time feed of all Pixium Vision filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pixium Vision
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pixium Vision via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-10 | N/A | Other | Sell | 42,681 | 16,517.55 EUR |
| 2024-01-09 | N/A | Other | Sell | 80,325 | 45,608.54 EUR |
| 2024-01-08 | N/A | Other | Sell | 110,740 | 69,732.98 EUR |
| 2023-12-04 | N/A | Other | Sell | 665 | 60.98 EUR |
Peer Companies
